BIOSTATS: Why Doesn't BioPharma Care about Costs?
Thursday, February 4 2010
12:00 pm – 2:00 pm
More often than not, biopharma executives' eyes glaze over when one discusses efficiency (cost control) as compared to new markets, new discoveries, or new acquisitions. Why is this, and how does it impact clinical development in general and clinical data management specifically?
This presentation will review why clinical development management misses the importance of controlling internal costs and instead tends to jump to the use of outsourcing, offshoring and "partners". These strategies confuse the components of cost, process, competencies and competitive advantage.
Using examples from data management and the use of technology, we will explore:
- false assumptions about the causes of operational dysfunction
- how process effectiveness is an underappreciated management too
- the role current functions must play in restoring control and responsibility.
Presenter: Ronald S. Waife, President, Waife & Associates, Inc.
Intended Audience: Project Managers, Line Managers and Directors of BDM and other clinical operations functions.
MassBio Calendar
Your source for events of interest to the biopharma and life sciences industry. Members-- have an event you'd like to share? Login to post it on our calendar.
Not a member? We will consider posting events we feel it will be of interest to our membership. Please send a short text description (100-150 words) about your event with a link for registration and additional information to membership@massbio.org.
Sign up for our Upcoming Events email which is sent each Friday (open to members and non-members) by emailing communications.